Search
for

    Sort by

    Research 571–600 of 1000+

    1. Novel compound heterozygous cadherin 3 mutations in hypotrichosis and juvenile macular dystrophy 2022 · 1 citations
    2. Acute Hair Loss 3 Years after Bone Marrow Transplant Skin appendage disorders · 2019 · 1 citations
    3. Development of 3-D Microbioreactor Systems for Cell-Based High Throughput Screening OhioLink ETD Center (Ohio Library and Information Network) · 2012 · 1 citations
    4. Volumes 2 and 3: The Head and Neck (Parts 1 and 2) Plastic and Reconstructive Surgery · 2007 · 1 citations
    5. Advances in Microbial Poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) over the Past 5 Years: Applications in Medicine, Food and Environment Journal of Polymer Science · 2026
    6. In Vivo and In Vitro Evaluation of PTeCA (1H‐Pyrrole‐2,3,4,5‐Tetracarboxylic Acid) in Hair Matrix as a Marker for Oxidative Cosmetic Treatment Drug Testing and Analysis · 2026
    7. Additional file 3 of ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata Figshare · 2026
    8. Additional file 3 of ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata Figshare · 2026
    9. Structure-activity relationship for calanthoside, a potential hairgrowth stimulant with an indole 2- <i>S</i> -,3- <i>O</i> -bis-glucoside structure. Part 1: Role of two glucoside moieties in promoting HFDPC proliferation RSC Medicinal Chemistry · 2026
    10. Pathogenic variants affecting peptidyl arginine deiminase 3 and its major substrates underlie central centrifugal cicatricial alopecia Journal of Investigative Dermatology · 2025
    11. Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial SKIN The Journal of Cutaneous Medicine · 2025
    12. Pathogenic variants affecting peptidyl arginine deiminase 3 and its major substrates underlie central centrifugal cicatricial alopecia. PubMed · 2025
    13. Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata Dermatology and Therapy · 2025
    14. Genetic Polymorphisms of the 3'-Untranslated Regions (3'-UTR) of the HSP 70 Gene in Moa Buffalo (Bubalus bubalis) Jurnal Penelitian Pendidikan IPA · 2025
    15. TOTAL SYNTHESIS OF THE ACTIVE INGREDIENT ACETYL TETRAPEPTIDE-3 FOR HAIR LOSS TREATMENT AND SCALP CARE Journal of Science Natural Science · 2025
    16. Influencing hair regrowth with EGCG by targeting glycogen synthase kinase-3β activity: a molecular dynamics study Journal of Receptors and Signal Transduction · 2025
    17. Electronic States of Epigallocatechin-3-Gallate in Water and in 1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (Sodium Salt) Liposomes Universidade Nova de Lisboa's Repository (Universidade Nova de Lisboa) · 2025
    18. NEDD4 Transcript Variant 3 and IGF-1 as Molecular Markers in the Development and Prognosis of Keloids The Egyptian Journal of Hospital Medicine · 2025
    19. Peer Review #3 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.1)" 2024
    20. 481 Pathogenic variants affecting peptidyl arginine deiminase 3 and its major substrates underlie central centrifugal cicatricial alopecia Journal of Investigative Dermatology · 2024
    21. The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study Egyptian Journal of Medical Human Genetics · 2024
    22. The zinc finger protein 3 of Arabidopsis thaliana regulates vegetative growth and root hair development Frontiers in plant science · 2024
    23. Molecular studies of transient receptor potential Vanilloid 3 (TRPV3) OPAL (Open@LaTrobe) (La Trobe University) · 2024
    24. The evaluation of IL-4 intron 3 VNTR and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with Alopecia Areata: a case-control study Research Square (Research Square) · 2023
    25. Low Molecular Weight Collagen Peptide (LMWCP) Promotes Hair Growth by Activating the Wnt/GSK-3β/β-Catenin Signaling Pathway Journal of microbiology and biotechnology · 2023
    26. Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study Dermatology and therapy · 2023
    27. 42175 PASI improvement in the first 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE guselkumab clinical trials Journal of the American Academy of Dermatology · 2023
    28. 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    29. Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study SKIN The Journal of Cutaneous Medicine · 2023
    30. Peer Review #3 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.2)" 2023